Found 33 matching trials
Ganetespib Window of Opportunity Study in Head and Neck Cancers PHASE1 This pilot clinical trial studies how well ganetespib works before surgery ...
Show More Location
Emory University Hospital Midtown
Learn More & Join Trial
PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer PHASE2 RATIONALE: Heat shock protein (HSP)90 inhibitor STA-9090 may stop the growt...
Show More Learn More & Join Trial
A Trial to Establish the Feasibility of Combining Either the Tyrosine Kinase Inhibitor AC220,CXCR4 Inhibitor Plerixafor or HSP90 Inhibitor Ganetespib With Chemotherapy in Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome. PHASE1 The AML18 Pilot Trial will evaluate the feasibility of three interventions ...
Show More Location
Aberdeen Royal Infirmary
Learn More & Join Trial
A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid Tumors PHASE1 This is an open-label, Phase 1, dose-escalation study to determine the reco...
Show More Location
Emory University School of Medicine
Learn More & Join Trial
A Study Evaluating STA-9090 in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST) PHASE2 The purpose of this study is to determine if STA-9090 is effective in the t...
Show More Location
UCLA Medical Center
Learn More & Join Trial
An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer PHASE2 The purpose of this study is to determine if ganetespib (STA-9090) is effec...
Show More Location
Synta Pharmaceuticals Investigative Site
Learn More & Join Trial
STA-9090 for Treatment of AML, CML, MDS and Myeloproliferative Disorders PHASE1 The purpose of this study is to characterize the safety and efficacy of STA...
Show More Location
Multiple Locations
Learn More & Join Trial
Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer PHASE1 This phase I trial studies the side effects and best dose of ganetespib whe...
Show More Location
NYU Cancer Institute
Learn More & Join Trial
Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy PHASE2 Hsp90 inhibitor STA-9090 may stop the growth of tumor cells by blocking som...
Show More Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital
Learn More & Join Trial
Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal Cancer PHASE1 The purpose of this study is to find out what effects, good and/or bad, the...
Show More Location
Emory University Winship Cancer Institute
Learn More & Join Trial